Production of Amoxicillin Microparticles by Supercritical Antisolvent Precipitation

Gallagher P. M., 1992, J. Supercrit. Fluids, 5, 142, 10.1016/0896-8446(92)90030-N

Reverchon E, 1998, J. Supercrit. Fluids, 15, 21

Subra P., 1999, Powder Technol., 103, 9, 10.1016/S0032-5910(99)00007-8

Gonda I.Pharmaceutics:  The Science of Dosage Form Design; Aulton, M. E., Ed.; Churchill Livinstone, 1988.

Altiere R. J., 1996, J., Ed.; New York, 94, 5

Mobley C., 2001, Drug Discuss. Today, 6, 375, 10.1016/S1359-6446(01)01691-9

Reverchon E., 2000, J. Supercrit. Fluids, 17, 248, 10.1016/S0896-8446(00)00045-0

Kalogiannis K., 2003, 6th International Symposium on Supercritical Fluids

Hanna M. H., 1996, Proceedings of the Respiratory Drug Delivery Conference V

Palakodaty S., 1998, Pharm. Res., 15, 1835, 10.1023/A:1011949805156

Shekunov B., 1999, J. Cryst. Growth, 198, 1345, 10.1016/S0022-0248(98)01022-7

Reverchon E., 2002, Int. J. Pharm., 243, 91, 10.1016/S0378-5173(02)00261-2

York P, 1999, Pharm. Sci. Technol. Today, 11, 440

Velaga P. S., 2002, Int. J. Pharm., 231, 166, 10.1016/S0378-5173(01)00870-5

Sze Tu L., 2002, Powder Technol., 126, 149

Mûller R. H., 1998, Int. J. Pharm., 160, 237, 10.1016/S0378-5173(97)00311-6

Merck index,1996,97.